Actemra

Made by

• Chugai (Roche)

Active Ingredient

Tocilizumab

Prospectus

Approval date

2005/4/11

Treats

• Castleman disease
• Large-vessel vasculitis
• Giant cell arteritis, Temporal arteritis
• Adult onset Still disease, Adult Still disease
• Juvenile idiopathic arthritis
• Rheumatoid arthritis

Dosages

• ACTEMRA for Intravenous Infusion - 14919円／瓶

• ACTEMRA for Intravenous Infusion - 36572円／瓶

• ACTEMRA for Intravenous Infusion - 73298円／瓶